Evidence map›Paper›PMID 33661891›Full record

ArticlePLoS neglected tropical diseases2021

Cost-effectiveness of the national dog rabies prevention and control program in Mexico, 1990-2015.

Jesús Felipe González-Roldán, Eduardo A Undurraga, Martin I Meltzer, Charisma Atkins, Fernando Vargas-Pino, Verónica Gutiérrez-Cedillo, José Ramón Hernández-Pérez

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Feasibility of Oral Rabies Vaccination of Dogs in Mexico.Tropical medicine and infectious disease · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Regulation of innate immune responses by rabies virus.Animal models and experimental medicine · 2022
    Review
  19. Article
  20. Rabies in the Tropics.Current tropical medicine reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Jesús Felipe González-RoldánCentro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE), Secretaría de Salud México, Ciudad de México, México.ORCID 0000-0003-2320-0593
Eduardo A UndurragaEscuela de Gobierno, Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile.ORCID 0000-0002-4425-1253
Martin I MeltzerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0002-7250-0472
Charisma AtkinsNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Fernando Vargas-PinoSubdirección de Rabia y otras Zoonosis del CENAPRECE, Ciudad de México, México.ORCID 0000-0003-3817-9651
Verónica Gutiérrez-CedilloSubdirección de Rabia y otras Zoonosis del CENAPRECE, Ciudad de México, México.ORCID 0000-0002-8429-6341
José Ramón Hernández-PérezCoordinador Estatal de Zoonosis, Secretaría de Salud Tlaxcala, México.ORCID 0000-0002-0518-6487
Centers for Disease Control and Prevention · USPontificia Universidad Católica de Chile · CLSecretaria de Salud · MXSecretaria de Salud · HN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRabies is a viral zoonosis that imposes a substantial disease and economic burden in many developing countries. Dogs are the primary source of rabies transmission; eliminating dog rabies reduces the risk of exposure in humans significantly. Through mass annual dog rabies vaccination campaigns, the national program of rabies control in Mexico progressively reduced rabies cases in dogs and humans since 1990. In 2019, the World Health Organization validated Mexico for eliminating rabies as a public health problem. Using a governmental perspective, we retrospectively assessed the economic costs, effectiveness, and cost-effectiveness of the national program of rabies control in Mexico, 1990-2015. METHODOLOGY: Combining various data sources, including administrative records, national statistics, and scientific literature, we retrospectively compared the current scenario of annual dog vaccination campaigns and post-exposure prophylaxis (PEP) with a counterfactual scenario without an annual dog vaccination campaign but including PEP. The counterfactual scenario was estimated using a mathematical model of dog rabies transmission (RabiesEcon). We performed a thorough sensitivity analysis of the main results. PRINCIPAL

findingsResults suggest that in 1990 through 2015, the national dog rabies vaccination program in Mexico prevented about 13,000 human rabies deaths, at an incremental cost (MXN 2015) of $4,700 million (USD 300 million). We estimated an average cost of $360,000 (USD 23,000) per human rabies death averted, $6,500 (USD 410) per additional year-of-life, and $3,000 (USD 190) per dog rabies death averted. Results were robust to several counterfactual scenarios, including high and low rabies transmission scenarios and various assumptions about potential costs without mass dog rabies vaccination campaigns.

conclusionsAnnual dog rabies vaccination campaigns have eliminated the transmission of dog-to-dog rabies and dog-mediated human rabies deaths in Mexico. According to World Health Organization standards, our results show that the national program of rabies control in Mexico has been highly cost-effective.

Indexed as

Cost-Benefit AnalysisAnimalsDog DiseasesDogsHumansMass VaccinationMexicoModels, TheoreticalPost-Exposure ProphylaxisRabiesRabies VaccinesRetrospective StudiesRabies Vaccines

Identifiers

PMID33661891
PMCPMC7963054
OpenAlexW3133787426

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.